| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/05/2002 | US20020123462 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 09/05/2002 | US20020123143 Cellular composition for use in the treatment and repair of bone and nervous system disorders |
| 09/05/2002 | US20020123141 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells |
| 09/05/2002 | US20020123119 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides and for treatment and prevention of infections |
| 09/05/2002 | US20020123099 Highly expressible genes |
| 09/05/2002 | US20020122836 Extract of Arales, Asterales, Coniferales, Equisetales, Euphorbiales, Geraniales, Lamiales, Lillales, Pteridophyta, Ranales, Rhamnales, Rutales, Scrophulariales, Umbellales, or Urticales. |
| 09/05/2002 | DE10110325A1 Phenylderivate 2 Phenyl derivatives 2 |
| 09/05/2002 | DE10109867A1 Verwendung von Triazolverbindungen zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie Use of triazole compounds for the prophylaxis and treatment of neurodegenerative diseases, brain trauma and cerebral ischemia |
| 09/05/2002 | DE10109866A1 Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie Triazole compounds and their use for the prophylaxis and therapy of neurodegenerative diseases, brain trauma and cerebral ischaemia |
| 09/05/2002 | DE10109861A1 Neuartige seitenkettenhalogenierte Aminodicarbonsäurederivate Novel side-chain halogenated Aminodicarbonsäurederivate |
| 09/05/2002 | DE10109859A1 Neuartige Aminodicarbonsäurederivate Novel Aminodicarbonsäurederivate |
| 09/05/2002 | DE10109763A1 Pharmazeutische Salze Pharmaceutical Salts |
| 09/05/2002 | DE10108752A1 Neue Substituierte Imidazotriazinone New Substituted imidazotriazinones |
| 09/05/2002 | DE10107731A1 Verwendung eines polyfunktionellen Wirkstoffgemisches als Tabakrauchschadstoffantagonist als gesundheitsschützendes Mittel beim Tabakrauchen Using a polyfunctional active ingredient mixture as tobacco smoke pollution antagonist with a health protective agent in tobacco smoking |
| 09/05/2002 | DE10106835A1 Signaltransduktionsproteine 15B3, 15B3-1 und 15B3-2 und zugrundeliegende DNA-Sequenzen Signal transduction 15B3, 15B3-1 and 15B3-2 and underlying DNA sequences |
| 09/04/2002 | EP1236800A2 Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1236723A1 Sulfamide derivatives useful as beta3 agonists and pharmaceutical uses thereof |
| 09/04/2002 | EP1236720A1 Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors |
| 09/04/2002 | EP1236468A1 Sulfonylaminocarbonyl derivatives for the treatment of nuclear factor-kappa B mediated diseases and disorders |
| 09/04/2002 | EP1236046A2 Methods for screening compounds active on neurons |
| 09/04/2002 | EP1235936A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1235934A2 Screening method for candidate drugs |
| 09/04/2002 | EP1235915A2 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
| 09/04/2002 | EP1235907A1 6 human secreted proteins |
| 09/04/2002 | EP1235860A2 G-protein coupled receptors |
| 09/04/2002 | EP1235858A1 Use of the insulin-like-growth factor i isoform mgf for the treatment of neurological disorders |
| 09/04/2002 | EP1235851A2 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 09/04/2002 | EP1235846A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235845A2 24 human secreted proteins |
| 09/04/2002 | EP1235844A1 28 human secreted proteins |
| 09/04/2002 | EP1235843A1 26 human secreted proteins |
| 09/04/2002 | EP1235838A1 23 human secreted proteins |
| 09/04/2002 | EP1235830A2 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 09/04/2002 | EP1235829A2 Pyrazolo 1,5-d] 1,2,4]triazines for enhancing cognition |
| 09/04/2002 | EP1235827A2 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 09/04/2002 | EP1235826A1 Quinuclidine acrylamides |
| 09/04/2002 | EP1235825A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 09/04/2002 | EP1235824A1 Vitamin d analogues |
| 09/04/2002 | EP1235815A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 09/04/2002 | EP1235814A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 09/04/2002 | EP1235812A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 09/04/2002 | EP1235809A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments |
| 09/04/2002 | EP1235808A2 Tricyclic analgesics |
| 09/04/2002 | EP1235803A1 Urea compounds having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235802A1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235798A1 1,4 substituted piperidinyl nmda/nr2b antagonists |
| 09/04/2002 | EP1235797A1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode |
| 09/04/2002 | EP1235789A2 $g(b)-AMINOACID COMPOUNDS USEFUL FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS |
| 09/04/2002 | EP1235787A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 09/04/2002 | EP1235776A1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 09/04/2002 | EP1235618A2 Bioconjugation in vivo to pulmonary or blood components |
| 09/04/2002 | EP1235594A2 Inhibition of secretion from non-neuronal cells |
| 09/04/2002 | EP1235593A2 Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith |
| 09/04/2002 | EP1235592A1 COMBINATION OF COMPOUNDS THAT INHIBIT THE BIOLOGICAL EFFECTS OF TNF-$g(a) AND CD95L IN A MEDICAMENT |
| 09/04/2002 | EP1235587A2 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases comprising all-d peptides |
| 09/04/2002 | EP1235580A2 Transdermal system containing acetylsalicylic acid for treatment of migraine |
| 09/04/2002 | EP1235578A2 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 09/04/2002 | EP1235576A2 Combinations of sumatriptan or naratriptan with cyclooxygenase ii inhibitor |
| 09/04/2002 | EP1235575A2 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
| 09/04/2002 | EP1235574A2 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 09/04/2002 | EP1235573A2 Combination of riluzole and gabapentin and use thereof as medicine |
| 09/04/2002 | EP1235572A2 Method to treat pain utilizing benzimidazole nmda/nr2b antagonists |
| 09/04/2002 | EP1235570A2 Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics |
| 09/04/2002 | EP1169314B1 Crystalline base of citalopram |
| 09/04/2002 | EP1150974B1 Heterocyclic derivatives as inhibitors of factor xa |
| 09/04/2002 | EP1140919B1 1,4-disubstituted cyclohexane derivatives for the treatment of depression |
| 09/04/2002 | EP1068184B1 N-aryloxyethylamine derivatives for the treatment of depression |
| 09/04/2002 | EP1056759B1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives |
| 09/04/2002 | EP1037646B1 Ginkgo biloba leaf extracts with a reduced 4'-o-methylpyridoxine and biflavone content |
| 09/04/2002 | EP1005471B1 Pyrazolo(3,4-d)pyrimidines with anticonvulsive and antiallergic/antiasthmatic action |
| 09/04/2002 | EP0934528B1 A method for the identification of compounds with anxiolytic potential |
| 09/04/2002 | EP0929525B1 Heteroaryloxyethylamines as 5-ht1a receptor ligands |
| 09/04/2002 | EP0906309B1 Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride |
| 09/04/2002 | EP0832074B1 Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists |
| 09/04/2002 | EP0830348B1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 09/04/2002 | EP0809636B1 Substituted isoxazoles for the treatment of inflammation |
| 09/04/2002 | EP0775143B1 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 09/04/2002 | EP0760664B1 Use of pteridine derivatives as no-synthase inhibitors |
| 09/04/2002 | EP0682526B1 PULMONARY ADMINISTRATION OF THE SOLUBLE COMPLEM RECEPTOR TYPE 1 sCR1 |
| 09/04/2002 | CN1367826A Method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 09/04/2002 | CN1367793A Neuromedin B and somatostatin receptor agonists |
| 09/04/2002 | CN1367792A Somatostatin agonists |
| 09/04/2002 | CN1367786A Method for preparation of citalopram |
| 09/04/2002 | CN1367783A Antipsychotic cyclic N-aralkyl amines |
| 09/04/2002 | CN1367782A Process for producing dibenzothiazepine derivatives |
| 09/04/2002 | CN1367775A Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation |
| 09/04/2002 | CN1367699A Composition containing extracts of butyrospermum parkii and use as medicament or dietary supplement |
| 09/04/2002 | CN1367697A Therapeutical method for improving cognition |
| 09/04/2002 | CN1367695A Phthalazine derivatives for treating inflammatory diseases |
| 09/04/2002 | CN1367693A Pharmaceutical compositions containing poly(ADP-ribose) glycohydrolase inhibitors and method of using the same |
| 09/04/2002 | CN1367692A Nicotine delivery systems |
| 09/04/2002 | CN1367245A Technique for inducing and converting nerve trunk cell into dopaminergic neurons |
| 09/04/2002 | CN1367169A Substituted 6,6-Hetero-dicycloderivative |
| 09/04/2002 | CN1367002A Pure Chinese medicine for giving up drugs and its preparation method |
| 09/04/2002 | CN1366988A Health-care tea as cigarette companion and its preparation method |
| 09/04/2002 | CN1366948A Nano Fufang Fufangteng preparation medicine and preparation method |
| 09/04/2002 | CN1366933A Nano Qiyeshen'an preparation medicine and preparation method |
| 09/04/2002 | CN1366928A Nano antelope horn preparation medicine and preparation method |
| 09/04/2002 | CN1366917A Nano Neibu Yangrong preparation medicine and preparation method |
| 09/04/2002 | CN1366915A Nano brain-benefiting blood pressure-reducing preparation medicine and preparation method |